Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0001213900-25-043211·Alaunos Therapeutics, Inc.
Schedule 13D ownership disclosure
ALAUNOS THERAPEUTICS INC
Common Stock · CUSIP: 98973P309
Event date: 2025-05-12
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- PMGC CAPITAL LLCReported CIK 0002068010
Shares: 83,500.00 · Class: 5.09295%
- PMGC Holdings Inc.Reported CIK 0001840563
Shares: 83,500.00 · Class: 5.09295%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-25-043211
- Form type
- SCHEDULE 13D
- Filer
- Alaunos Therapeutics, Inc.
- CIK
- CIK 1107421
- Filed
- May 14, 2025
- Reporting period
- May 12, 2025
- Description
- Schedule 13D beneficial ownership